T1	disease_or_phenotypic_feature 0 21	Peripheral neuropathy
T2	chemical 94 98	drug
T3	chemical 100 110	paclitaxel
T4	chemical 112 121	Phenytoin
T5	chemical 122 130	rifampin
T6	chemical 131 135	drug
T7	disease_or_phenotypic_feature 170 183	renal failure
T8	disease_or_phenotypic_feature 222 229	obesity
T9	chemical 230 237	hormone
T10	chemical 238 244	leptin
T12	chemical 348 356	antigens
T13	disease_or_phenotypic_feature 373 387	stomach tumors
T14	disease_or_phenotypic_feature 390 408	Malignant melanoma
T15	chemical 413 421	androgen
T16	chemical 489 497	antigens
T17	disease_or_phenotypic_feature 581 595	bladder tumors
T18	chemical 736 740	drug
T19	disease_or_phenotypic_feature 850 856	cancer
T20	disease_or_phenotypic_feature 895 907	Fibrosarcoma
T21	chemical 935 943	estrogen
T22	chemical 961 972	Biochemical
T23	chemical 1005 1014	phenytoin
T24	disease_or_phenotypic_feature 1023 1035	cleft palate
T25	chemical 1050 1054	acid
T26	disease_or_phenotypic_feature 1074 1082	cataract
T27	chemical 1109 1120	bupivacaine
T28	disease_or_phenotypic_feature 1152 1158	cancer
T29	disease_or_phenotypic_feature 1159 1163	pain
T30	chemical 1185 1192	dextran
T31	chemical 1193 1207	sodium sulfate
T32	disease_or_phenotypic_feature 1213 1216	DSS
T33	disease_or_phenotypic_feature 1227 1234	colitis
T34	chemical 1255 1264	inhibitor
T35	disease_or_phenotypic_feature 1312 1323	Vaccination
T36	chemical 1366 1374	antigens
T37	disease_or_phenotypic_feature 1460 1466	cancer
T38	chemical 1529 1536	antigen
T39	chemical 1573 1581	effector
T40	chemical 1616 1627	antagonists
T41	disease_or_phenotypic_feature 1698 1711	heart failure
T42	disease_or_phenotypic_feature 1716 1728	hypertension
T43	chemical 1759 1770	antagonists
T44	disease_or_phenotypic_feature 1808 1824	vascular disease
T45	disease_or_phenotypic_feature 1826 1833	obesity
T46	disease_or_phenotypic_feature 1835 1842	obesity
T47	disease_or_phenotypic_feature 1869 1887	metabolic syndrome
T48	chemical 1907 1913	oxygen
T49	disease_or_phenotypic_feature 1951 1958	anxiety
T50	chemical 1970 1976	oxygen
T51	disease_or_phenotypic_feature 1992 2005	heart failure
T52	disease_or_phenotypic_feature 2092 2100	melanoma
T53	chemical 2132 2141	phosphate
T54	chemical 2142 2150	buffered
T55	chemical 2151 2157	saline
T56	chemical 2184 2191	alcohol
T57	chemical 2209 2218	cofactors
T58	chemical 2227 2234	tobacco
T59	disease_or_phenotypic_feature 2236 2243	obesity
T60	chemical 2276 2286	inhibitors
T61	chemical 2295 2303	D-JNKI-1
T62	disease_or_phenotypic_feature 2325 2331	cancer
T63	disease_or_phenotypic_feature 2332 2336	pain
T64	chemical 2338 2344	Yeasts
T65	chemical 2361 2369	antigens
T66	disease_or_phenotypic_feature 2373 2379	cancer
R2	causes_or_contributes_to Arg1:T3 Arg2:T1	
T68	corrected_chemical 222 237	obesity hormone
T11	disease_or_phenotypic_feature 281 287	cancer
T69	corrected_disease_or_phenotypic_feature 281 299	cancer development
T70	missed_disease_or_phenotypic_feature 281 287;304 315	cancer progression
R3	causes_or_contributes_to Arg1:T68 Arg2:T69	
R4	causes_or_contributes_to Arg1:T10 Arg2:T69	
R5	causes_or_contributes_to Arg1:T68 Arg2:T70	
R6	causes_or_contributes_to Arg1:T10 Arg2:T70	
T71	corrected_chemical 335 356	glycoprotein antigens
T75	missed_chemical 986 1000	glucocorticoid
R10	causes_or_contributes_to Arg1:T75 Arg2:T24	
R11	causes_or_contributes_to Arg1:T23 Arg2:T24	
T76	corrected_disease_or_phenotypic_feature 1140 1163	intractable cancer pain
T77	corrected_chemical 1109 1136	bupivacaine-opioid infusion
R12	treats Arg1:T77 Arg2:T76	
T78	corrected_chemical 1251 1264	MK2 inhibitor
T79	missed_disease_or_phenotypic_feature 1293 1298	tumor
R13	treats Arg1:T78 Arg2:T79	
T80	corrected_disease_or_phenotypic_feature 1227 1249	colitis-associated CRC
T81	corrected_chemical 1172 1184	azoxymethane
T82	missed_chemical 1213 1216	DSS
R14	causes_or_contributes_to Arg1:T81 Arg2:T80	
R15	causes_or_contributes_to Arg1:T82 Arg2:T80	
T83	corrected_chemical 1349 1374	tumor-associated antigens
T84	missed_disease_or_phenotypic_feature 1332 1338	tumors
R16	treats Arg1:T83 Arg2:T84	
T85	missed_chemical 1411 1448	synthetic peptides used as immunogens
R17	treats Arg1:T85 Arg2:T84	
T87	corrected_chemical 1613 1627	MR antagonists
R19	treats Arg1:T87 Arg2:T41	
R20	treats Arg1:T87 Arg2:T42	
T88	corrected_disease_or_phenotypic_feature 1835 1863	obesity-related hypertension
T89	corrected_disease_or_phenotypic_feature 2325 2336	cancer pain
T90	corrected_chemical 2272 2286	JNK inhibitors
R25	treats Arg1:T90 Arg2:T89	
R26	treats Arg1:T61 Arg2:T89	
T91	corrected_chemical 2354 2369	tumour antigens
T73	corrected_chemical 1756 1770	MR antagonists
R18	treats Arg1:T73 Arg2:T44	
R21	treats Arg1:T73 Arg2:T45	
R22	treats Arg1:T73 Arg2:T88	
R23	treats Arg1:T73 Arg2:T47	
T67	missed_chemical 1312 1323	Vaccination
R1	treats Arg1:T67 Arg2:T84	
R7	causes_or_contributes_to Arg1:T2 Arg2:T1	
T72	missed_disease_or_phenotypic_feature 58 69	side effect
R8	causes_or_contributes_to Arg1:T2 Arg2:T72	
R9	causes_or_contributes_to Arg1:T3 Arg2:T72	
R24	treats Arg1:T78 Arg2:T80	
T74	missed_chemical 1209 1212	AOM
R27	causes_or_contributes_to Arg1:T74 Arg2:T80	
T86	corrected_chemical 1185 1207	dextran sodium sulfate
R28	causes_or_contributes_to Arg1:T86 Arg2:T80	
T92	missed_chemical 1643 1648	drugs
R29	treats Arg1:T92 Arg2:T41	
R30	treats Arg1:T92 Arg2:T42	
